Stay updated on Pembrolizumab for High Risk Oral Neoplasia Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for High Risk Oral Neoplasia Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for High Risk Oral Neoplasia Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, replacing the study details content with a standard error screen. This indicates access to the NCT02882282 study record is blocked at the moment.
    Difference
    19%
    Check dated 2026-09-20T23:00:18.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    The page revision indicator was updated from v3.6.5 to v3.6.6. No study content or data were changed.
    Difference
    0.1%
    Check dated 2026-08-30T21:42:15.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    Page revision updated from v3.6.4 to v3.6.5, indicating an internal update to the document version rather than a modification to the study information shown to users.
    Difference
    0.1%
    Check dated 2026-08-09T08:41:25.000Z thumbnail image
  6. Check
    68 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.4, replacing v3.6.3, signaling that a newer version of the study document is referenced on the page.
    Difference
    0.1%
    Check dated 2026-07-25T18:02:16.000Z thumbnail image
  7. Check
    89 days ago
    Change Detected
    Summary
    The page shows a new revision tag (v3.6.3) replacing v3.6.2, indicating a minor software update. No study details or content appear affected by this change.
    Difference
    0.1%
    Check dated 2026-07-04T08:11:13.000Z thumbnail image
  8. Check
    96 days ago
    Change Detected
    Summary
    The page revision was updated from `v3.6.0` to `v3.6.2`, indicating a backend update; no substantive study details appear to be affected.
    Difference
    0.1%
    Check dated 2026-06-27T03:26:16.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for High Risk Oral Neoplasia Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for High Risk Oral Neoplasia Clinical Trial page.